This trial is focused on the feasibility of implementing an electronic alert system to notify patients and doctors of high LDL-C values. 400 patients will be randomly selected to either receive notifications or not.
1 Primary · 1 Secondary · Reporting Duration: 90 days
400 Total Participants · 2 Treatment Groups
Primary Treatment: Alert · No Placebo Group · N/A
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: